Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022

The global clinical trial management system market is expected to reach USD 1,065.6 Million by 2022 from USD 534.1 Million in 2016, at a CAGR of 12.6%. The time frame considered for the study are as follows:

• Base Year: 2016
• Forecast Period: 2017–2022

Objectives of the study are:

• To define, describe, segment, and forecast the global clinical trial management systems market by type, delivery mode, component, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the global CTMS market (drivers, restraints, opportunities, and challenges)
• To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the market value of market segments with respect to the four key regions, namely, North America (US, and Canada), Europe (Germany, UK, France and RoE), Asia Pacific (China, Japan, India and RoAPAC), and the Rest of the World
• To profile the key players in the global CTMS market and comprehensively analyze their market rank and core competencies2
• To track and analyze competitive developments such as product launches and enhancements; partnerships, agreements, and collaborations; mergers and acquisitions; and expansions in the global clinical trial management system market

This research study involves the extensive use of secondary sources, directories, and databases (such as Dun & Bradstreet, Bloomberg Business, and Factiva), to identify and collect information useful for this technical, market-oriented, and financial study of the CTMS market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

To know about the assumptions considered for the study, download the pdf brochure

As of 2017, Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US) held the leading position in the global clinical trial management systems market. These companies adopted product launches, enhancements, agreements, partnerships, and collaborations as their key growth strategies in the past three years. DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US) are some of the other major players in this market.

Stakeholders

• Healthcare IT service providers
• Pharmaceutical/biopharmaceutical companies
• Clinical research organizations
• Research and development (R&D) companies
• Medical device companies
• Business research and consulting service providers
• Academic medical centers/universities/hospitals

Scope of the Report

This report categorizes the global CTMS market into the following segments and subsegments:

Global Clinical Trial Management Systems Market, by Type

• Enterprise CTMS
• Site CTMS

Global Clinical Trial Management Systems Market, by Delivery Mode

• Web-based (Hosted) CTMS
• Licensed Enterprise (On Premise) CTMS
• Cloud-based (SaaS) CTMS

Global Clinical Trial Management Systems Market, by Component

• Software
• Services

 Global Clinical Trial Management Systems Market, by End User

• Pharmaceutical and Biopharmaceutical Companies
  • Large
  • Mid-small
• Contract Research Organizations
• Medical Device Companies
• Other End Users
• Note: Other End Users include hospitals and academic research institutions among others

Global Clinical Trial Management Systems Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC
• Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

• Product matrix which gives a detailed comparison of the product portfolios of the top five companies

Company Information

• Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency Used
    1.5 Market Stakeholders 

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
           2.1.2 Primary Data
    2.2 Market Size Estimation
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary

4 Premium Insights
    4.1 Clinical Trial Management Systems Market: Overview (2017–2022)
    4.2 Global Clinical Trial Management System Market, By Component, 2017 vs 2022
    4.3 Global Clinical Trial Managements System Market, By Type, 2017 vs 2022
    4.4 Global Clinical Trial Management System Market, By End-User and Mode of Delivery (2017)
    4.5 Clinical Trial Management System  Market By Country, 2017

5 Market Overview
    5.1 Drivers
    5.2 Restraints
    5.3 Opportunities
    5.4 Challenges
    5.5 Key Industry Trends

6 Clinical Trial Management Systems Market, By Type
    6.1 Introduction
    6.2 Enterprise CTMS 
    6.3 Site CTMS 

7 Clinical Trial Management Systems Market, By Delivery Mode
    7.1 Introduction
    7.2 Web-Based (Hosted) CTMS 
    7.3 Licensed Enterprise (On Premise) CTMS
    7.4 Cloud-Based (SaaS) CTMS

8 Clinical Trial Management System Market, By Component
    8.1 Introduction
    8.2 Softwares
    8.3 Services

9 Clinical Trial Management System Market, By End User
    9.1 Introduction
    9.2 Pharmaceutical and Biopharmaceutical Companies
           9.2.1 Large Pharmaceutical Companies
           9.2.2 Mid-Small Pharmaceutical Companies
    9.3 Contract Research Organizations
    9.4 Medical Device Companies
    9.5 Other End Users

10 Clinical Trial Management Systems Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.1 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 UK
             10.3.3 France
             10.3.4 Rest of Europe (RoE)
     10.4 Asia Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape
     11.1 Overview
     11.2 Clinical Trial Management Systems Market Share Analysis, By Key Players (2016) 
     11.3 Competitive Scenario and Trends
             11.3.1 Product Launches and Enhancements (2014–2017)
             11.3.2 Agreements, Partnerships, and Collaborations (2014–2017)
             11.3.3 Market Expansions (2014–2017)
             11.3.4 Mergers and Acquisitions (2014–2017)

*Top 15 Companies Analyzed for This Studies are - Oracle (US), Medidata Solutions (US), Parexel (US), Bioclinica (US), Bio-Optronics (US), IBM (US), Datatrak (US), Veeva Systems (US), DSG (US), Mastercontrol (US), ERT (US), Forte Research Systems (US), Mednet Solutions (US), Arisglobal (US), and DZS Software Solutions (US).

12 Company Profiles
(Introduction, Products & Services, Financial Snapshots, Developments, MnM View)*
     12.1 Oracle
     12.2 Medidata Solutions
     12.3 Parexel
     12.4 Bioclinica
     12.5 Bio-Optronics
     12.6 IBM
     12.7 Datatrak
     12.8 Veeva Systems
     12.9 DSG 
     12.10 Mastercontrol
     12.11 ERT 
     12.12 Forte Research Systems
     12.13 Mednet Solutions
     12.14 Arisglobal
     12.15 DZS Software Solutions

*Details on Marketsandmarkets View, Introduction, Product & Services, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
     13.1 Discussion Guide
     13.2 Knowledge Store
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports 
     13.6 Authors Details

List of Tables (88 Tables)

Table 1 List of Partnerships Between Biopharma Companies and CROs
Table 2 Global Clinical Trial Management Systems Market, By Type, 2017–2022 (USD Million)
Table 3 CTMS Market for Enterprise CTMS, By Region, 2017–2022 (USD Million)
Table 4 Clinical Trial Management System Market for Site CTMS, By Region, 2017–2022 (USD Million)
Table 5 Global CTMS Market, By Delivery Mode, 2015–2022 (USD Million)
Table 6 Web-Based (On-Demand) Clinical Trial Management Systems Market, By Region, 2015–2022 (USD Million)
Table 7 Licensed Enterprise (On-Premise) CTMS Market, By Region, 2015–2022 (USD Million)
Table 8 Cloud-Based (SaaS) Clinical Trial Management Systems Market, By Region, 2015–2022 (USD Million)
Table 9 Global CTMS Market, By Component, 2017–2022 (USD Million)
Table 10 Clinical Trial Management System Market for Software By Region, 2017–2022 (USD Million)
Table 11 CTMS Market for Services By Region, 2017–2022 (USD Million)
Table 12 Global Clinical Trial Management Systems Market, By End User, 2017–2022 (USD Million)
Table 13 CTMS Market for Pharmaceutical and Biopharmaceutical Companies By Region, 2017–2022 (USD Million)
Table 14 Clinical Trial Management System Market for Pharmaceutical and Biopharmaceutical Companies By Type, 2017–2022 (USD Million)
Table 15 CTMS Market for Large Pharmaceutical Companies By Region, 2017–2022 (USD Million)
Table 16 Clinical Trial Management Systems Market for Small-Mid Sized Pharamceutical Companies By Region, 2017–2022 (USD Million)
Table 17 Strategic Alliances Between CROs and Pharma Companies (2011–2015)
Table 18 CTMS Market for CRO By Region, 2017–2022 (USD Million)
Table 19 Clinical Trial Management System Market for Medical Device Companies By Region, 2017–2022 (USD Million)
Table 20 CTMS Market for Other End Users By Region, 2017–2022 (USD Million)
Table 21 Clinical Trial Management Systems Market, By Region, 2015–2022 (USD Million)
Table 22 North America: CTMS Market, By Country, 2015–2022 (USD Million)
Table 23 North America: Clinical Trial Management System Market, By Component, 2015–2022 (USD Million)
Table 24 North America: CTMS Market, By Type, 2015–2022 (USD Million)
Table 25 North America: Clinical Trial Management Systems Market, By Delivery Mode, 2015–2022 (USD Million)
Table 26 North America: CTMS Market, By End User, 2015–2022 (USD Million)
Table 27 North America: Pharmaceutical and Biopharmaceutical Companies Market, By Type, 2015–2022 (USD Million)
Table 28 US: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 29 US: CTMS Market, By Component, 2015–2022 (USD Million)
Table 30 US: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 31 US: CTMS Market, By End User, 2015–2022 (USD Million)
Table 32 Canada: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 33 Canada: CTMS Market, By Type, 2015–2022 (USD Million)
Table 34 Canada: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 35 Canada: CTMS Market, By End User, 2015–2022 (USD Million)
Table 36 Europe: Clinical Trial Management Systems Market, By Country, 2015–2022 (USD Million)
Table 37 Europe : CTMS Market, By Component, 2015–2022 (USD Million)
Table 38 Europe : Clinical Trial Management System Market, By Type, 2015–2022 (USD Million)
Table 39 Europe : CTMS Market, By Delivery Mode, 2015–2022 (USD Million)
Table 40 Europe : Clinical Trial Management Systems Market, By End User, 2015–2022 (USD Million)
Table 41 Europe : Pharmaceutical and Biopharmaceutical Companies Market, By Type, 2015–2022 (USD Million)
Table 42 Germany: Clinical Trial Management System Market, By Component, 2015–2022 (USD Million)
Table 43 Germany: CTMS Market, By Type, 2015–2022 (USD Million)
Table 44 Germany: Clinical Trial Management Systems Market, By Delivery Mode, 2015–2022 (USD Million)
Table 45 Germany: CTMS Market, By End User, 2015–2022 (USD Million)
Table 46 UK: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 47 UK: CTMS Market, By Type, 2015–2022 (USD Million)
Table 48 UK: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 49 UK: CTMS Market, By End User, 2015–2022 (USD Million)
Table 50 France: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 51 France: CTMS Market, By Type, 2015–2022 (USD Million)
Table 52 France : Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 53 France : CTMS Market, By End User, 2015–2022 (USD Million)
Table 54 RoE: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 55 RoE: CTMS Market, By Type, 2015–2022 (USD Million)
Table 56 RoE: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 57 RoE: CTMS Market, By End User, 2015–2022 (USD Million)
Table 58 APAC: Clinical Trial Management Systems Market, By Country, 2015–2022 (USD Million)
Table 59 APAC: CTMS Market, By Component, 2015–2022 (USD Million)
Table 60 APAC: Clinical Trial Management System Market, By Type, 2015–2022 (USD Million)
Table 61 APAC: CTMS Market, By Delivery Mode, 2015–2022 (USD Million)
Table 62 APAC: Clinical Trial Management Systems Market, By End User, 2015–2022 (USD Million)
Table 63 APAC: Pharmaceutical and Biopharmaceutical Companies Market, By Type, 2015–2022 (USD Million)
Table 64 China: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 65 China: CTMS Market, By Type, 2015–2022 (USD Million)
Table 66 China: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 67 China: CTMS Market, By End User, 2015–2022 (USD Million)
Table 68 Japan: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 69 Japan: CTMS Market, By Type, 2015–2022 (USD Million)
Table 70 Japan: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 71 Japan: CTMS Market, By End User, 2015–2022 (USD Million)
Table 72 India: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million)
Table 73 India: CTMS Market, By Type, 2015–2022 (USD Million)
Table 74 India: Clinical Trial Management System Market, By Delivery Mode, 2015–2022 (USD Million)
Table 75 India: CTMS Market, By End User, 2015–2022 (USD Million)
Table 76 RoAPAC: Clinical Trial Management Systems Market, By Component, 2015–2022 (USD Million))
Table 77 RoAPAC: CTMS Market, By Type, 2015–2022 (USD Million)
Table 78 RoAPAC: Clinical Trial Management Systems Market, By Delivery Mode, 2015–2022 (USD Million))
Table 79 RoAPAC: CTMS Market, By End User, 2015–2022 (USD Million)
Table 80 RoW: Clinical Trial Management System Market, By Component, 2015–2022 (USD Million)
Table 81 RoW: CTMS Market, By Type, 2015–2022 (USD Million)
Table 82 RoW: Clinical Trial Management Systems Market, By Delivery Mode, 2015–2022 (USD Million)
Table 83 RoW: CTMS Market, By End User, 2015–2022 (USD Million)
Table 84 RoW: Pharmaceutical and Biopharmaceutical Companies Market, By Type, 2015–2022 (USD Million)
Table 85 Product Launches and Enhancements (2014–2017)
Table 86 Agreements, Partnerships, and Collaborations (2014–2017)
Table 87 Market Expansions (2014–2017)
Table 88 Mergers and Acquisitions (2014–2017)

List of Figures (46 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries
Figure 3 Enterprise CTMS Segment to Hold the Largest Share of the Clinical Trial Management Systems Market in 2017
Figure 4 Software Segment to Hold the Largest Share in the CTMS Market During 2017–2022
Figure 5 Web-Based CTMS Segment to Hold the Largest Share in the Clinical Trial Management System Market During the Forecast Period
Figure 6 CTMS Market, By End User, 2017 vs 2022
Figure 7 North America to Dominate the Global Clinical Trial Management Systems Market During the Forecast Period
Figure 8 Rising Number of Clinical Trials to Drive the Growth of the Market (2017–2022)
Figure 9 Software Platforms to Dominate the Global CTMS Market Till 2022
Figure 10 Enterprise Based CTMS Platforms to Dominate the Global Clinical Trial Management System Market Till 2022
Figure 11 Web-Based CTMS and Pharmaceutical Companies to Dominate the CTMS Market in 2017
Figure 12 China to Be the Fastest-Growing Markets for CTMS During the Forecast Period
Figure 13 Market Dynamics: Driver, Restraints, Opportunities and Challenges
Figure 14 Global Increase in the Number of Clinical Trials, 2002–2017
Figure 15 Global Clinical Trial Management Systems Market Share, By Type, 2017 vs 2022
Figure 16 Enterprise CTMS Market Share, By Geography (2017)
Figure 17 Site Clinical Trial Management System Market Share, By Geography (2017)
Figure 18 Global CTMS Market, By Mode of Delivery (2017 vs 2022)
Figure 19 Web-Based (On-Demand) Segment to Dominate the Global Clinical Trial Management System Market in 2017
Figure 20 Web-Based (On Demand) CTMS Market Share, By Region(2017)
Figure 21 Licensed Enterprise (On-Premise) Clinical Trial Management Systems Market Share, By Region (2017)
Figure 22 Cloud-Based (SaaS) CTMS Market Share, By Region (2017)
Figure 23 Software Segment to Dominate the Global CTMS Solutions Market in 2017
Figure 24 Software Market Share, By Geography (2017)
Figure 25 Services Market Share, By Geography (2017)
Figure 26 Global Clinical Trial Management System Market, By End User, 2017
Figure 27 Pharmaceutical and Biopharmaceutical Companies Segment to Dominate the Global CTMS Market in 2017
Figure 28 R&D Expenditure of Major Pharmaceutical Companies, 2015 vs 2016 (USD Million)
Figure 29 Pharmaceutical Companies Market Share, By Geography (2017)
Figure 30 Large Pharmaceutical Companies Market Share, By Geography (2017)
Figure 31 Mid-Small Pharamceutical Companies Market Share, By Geography (2017)
Figure 32 CRO Services Cover the Entire Drug Development Spectrum
Figure 33 CRO Market Share, By Geography (2017)
Figure 34 Medical Device Companies Market Share, By Geography (2017)
Figure 35 Other End Users Market Share, By Geography (2017)
Figure 36 Clinical Trial Management Systems Market By Region (2017 vs 2022)
Figure 37 Total Number of Ongoing Clinical Trials, By Region (December 2017)
Figure 38 Europe: Pharmaceutical R&D Expenditure, By Country, 2015 (USD Million)
Figure 39 Key Developments By Leading Market Players in the CTMS Market, 2014-2017
Figure 40 Clinical Trial Management System Market Share Analysis, 2016
Figure 41 Oracle : Company Snapshot
Figure 42 Medidata Solutions: Company Snapshot
Figure 43 Parexel : Company Snapshot
Figure 44 IBM : Company Snapshot
Figure 45 Datatrak : Company Snapshot
Figure 46 Veeva Systems : Company Snapshot

The global clinical trial management system (CTMS) market is expected to reach USD 1,065.6 Million by 2022 from USD 590.0 Million in 2017, at a CAGR of 12.6%. Factors such as significant outsourcing of clinical trial research to CROs, rising number of clinical trials, availability of advanced CTMS solutions, and rising government funds & grants to support clinical trials are driving the overall demand for CTMS across key markets.

This report broadly segments the clinical trial management system market into type, delivery mode, component, end user, and region. On the basis of by type, the CTMS market is segmented into enterprise CTMS and site CTMS. The enterprise CTMS segment is expected to command the largest share of the global clinical trial management system market in 2017, and is expected to grow at the highest CAGR in the forecast period. This is attributed to the global adoption of enterprise CTMS by majority of the end users.

On the basis of delivery mode, the global clinical trial management systems market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The web-based CTMS expected to command the largest share of the global CTMS market in 2017. This is attributed to benefits provided by the web-based CTMS solution such as improves quality of clinical trials, productivity and timelines, ease of access that enables faster transfer of data and easier co-relative studies and reduced cost offered than other products.

By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the clinical trial management system market in 2017. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies.

Factors such as cost constraints associated with emerging markets and lack of awareness among researchers about the advantages of CTMS solutions may hamper the growth of the market.

The report covers the CTMS market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global clinical trial management systems market primarily due to the high number of ongoing clinical trials, rising government support for conducting clinical trials, and presence of a large customer base in this region. However, Asia Pacific is expected to register the highest growth rate during the forecast period. Factors driving growth in the APAC region include the increasing outsourcing of clinical trials, availability of a large and diverse patient population, presence of supportive regulatory guidelines for clinical trials (as compared to developed nations), and cost advantages offered by countries in the region.

As of 2017, some of the major players operating in this market are Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst